Abstract
Summary
Despite the wide availability of a wide variety of approved osteoporosis medications and DXA scan centers in Egypt, only a minority of patients at high risk of sustaining a fragility fracture receive treatment, even after their first fracture. Such big “treatment gap” leaves the most high-risk individuals unprotected against fragility fractures. This study provides a benchmark to monitor national trends in osteoporosis management and service uptake.
Purpose
To assess the treatment gap among men and postmenopausal women presenting with a fragility fracture, and to analyze the characteristics and fracture risks of the patients presenting with an index fragility fracture.
Methods
This was a multi-center, cross-sectional, observational study. Both men and postmenopausal women, admitted with an osteoporotic fracture (whether major osteoporosis or hip fracture), were consecutively recruited for this work. The fracture risk was assessed based on their FRAX calculation prior to the index fracture. All the patients were assessed for their falls and sarcopenia risks. Blood tests for bone profile as well as DXA scan were offered to all the patients.
Results
Two hundred and thirty-six patients presenting with fragility fractures were included in this work. 70.8% were women and 29.2% were men. Mean age was 70.1 (SD = 9.2) years. Ten-year probability of fracture (without BMD) was high in 65.9% of the postmenopausal women and 40.3% of the men. 82.1% of the postmenopausal women and 100% in men identified to be eligible for osteoporosis therapy did not receive any form of osteoporosis therapy. FRAX score correlated significantly with bone mineral density assessment at both hip and spine. Falls, sarcopenia, and functional disability showed significant relation to the fracture risk.
Conclusions
There is a large treatment gap in Egyptian older adults. The recent guidelines for osteoporosis management in Egypt endorsed fracture centric approach to identify people at risk. The gap appears to be related to a low rate of osteoporosis diagnosis and lack of patient education.
Similar content being viewed by others
References
Eastell R, Rosen CJ, Black DM, Cheung AM, Murad MH, Shoback D (2019) Pharmacological management of osteoporosis in postmenopausal women: an Endocrine Society* clinical practice guideline. J Clin Endocrinol Metab 104(5):1595–1622
Johansson H, Siggeirsdottir K, Harvey NC, Oden A, Gudnason V, McCloskey E et al (2017) Imminent risk of fracture after fracture. Osteoporos Int 28(3):775–780
Kanis JA, Svedbom A, Harvey N et al (2014) The osteoporosis treatment gap. J Bone Miner Res 29:1926–1928
McCloskey E, Rathi J, Heijmans S, Blagden M, Cortet B, Czerwinski E, Hadji P, Payer J, Palmer K, Stad R, O'Kelly J, Papapoulos S (2021) The osteoporosis treatment gap in patients at risk of fracture in European primary care: a multi-country cross-sectional observational study. Osteoporos Int 32(2):251–259
Compston JE, McClung MR, Leslie WD (2019) Osteoporosis Lancet 393:364–376
Kanis JA, Johnell O, Oden A et al (2008) FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int 19(4):385–397
El-Tawab SS, Saba EKA, Elweshahi HMT, Ashry MH (2016) Knowledge of osteoporosis among women in Alexandria (Egypt): a community based survey. Egypt Rheumatol 38(3):225–231
El Miedany Y, Abu-Zaid MH, El Gaafary M et al (2021) Egyptian consensus on treat-to-target approach for osteoporosis: a clinical practice guideline from the Egyptian Academy of bone health and metabolic bone diseases. Egypt Rheumatol Rehabil 48:5
NIH Consensus Development Panel on Osteoporosis Prevention (2001) Diagnosis, and Therapy. Osteoporosis prevention, diagnosis, and therapy. JAMA 285(6):785–795
El Miedany Y, El Gaafary M, Toth M, Palmer D, Ahmed I (2011) Falls risk assessment score (FRAS): time to rethink. J Clin Gerontol Geriatr 2(1):21–26
Malmstrom TK, Miller DK, Simonsick EM, Ferrucci L, Morley JE (2016) SARC-F: a symptom score to predict persons with sarcopenia at risk for poor functional outcomes. J Cachexia Sarcopenia Muscle 7(1):28–36
El Miedany Y, El Gaafary M, Youssef SS, Palmer D (2010) Incorporating patient reported outcome measures in clinical practice: development and validation of a questionnaire for inflammatory arthritis. Clin Exp Rheumatol 28(5):734–744
Gadallah N, El Miedany Y (2022) Operative secondary prevention of fragility fractures: national clinical standards for fracture liaison service in Egypt—an initiative by the Egyptian Academy of Bone Health. Egypt Rheumatol Rehabil 49:11
Schnell AD, Curtis JR, Saag KG (2018 Dec) Importance of recent fracture as predictor of imminent fracture risk. Curr Osteoporos Rep 16(6):738–745
Roux C, Briot K (2017 Jun) Imminent fracture risk. Osteoporos Int 28(6):1765–1769. https://doi.org/10.1007/s00198-017-3976-5
Hadji P, Schweikert B, Kloppmann E, Gille P, Joeres L, Toth E, Möckel L, Glüer CC (2021 Sep) Osteoporotic fractures and subsequent fractures: imminent fracture risk from an analysis of German real-world claims data. Arch Gynecol Obstet 304(3):703–712
El Miedany Y, Gadallah NA, Toth M (2022) Optimizing osteoporosis management: targeting to treat — an initiative by the Egyptian Academy of Bone Health. Egypt Rheumatol Rehabil 49:61
Ström O, Borgström F, Kanis JA et al (2011) Osteoporosis: burden, health care provision and opportunities in the EU. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Arch Osteoporos 6:59–155
Kanis JA, Cooper C, Rizzoli R et al (2017) Identification and management of patients at increased risk of osteoporotic fracture: outcomes of an ESCEO expert consensus meeting. Osteoporos Int 28:2023–2034
Abouzid MR, Ali K, Elkhawas I, Elshafei SM (2022) An overview of diabetes mellitus in Egypt and the significance of integrating preventive cardiology in diabetes management. Cureus 14(7):e27066
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
None.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
El Miedany, Y., El Gaafary, M., Gadallah, N. et al. Osteoporosis treatment gap in patients at risk of fracture in Egypt: a multi-center, cross-sectional observational study. Arch Osteoporos 18, 58 (2023). https://doi.org/10.1007/s11657-023-01252-8
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s11657-023-01252-8